Literature DB >> 18181564

Synthesis and biological activity of human neuropeptide S analogues modified in position 2.

Valeria Camarda1, Claudio Trapella, Girolamo Calo, Remo Guerrini, Anna Rizzi, Chiara Ruzza, Stella Fiorini, Erika Marzola, Rainer K Reinscheid, Domenico Regoli, Severo Salvadori.   

Abstract

Neuropeptide S (NPS) has been identified as the endogenous ligand of a previously orphan receptor now named NPSR. Previous studies demonstrated that the N-terminal sequence Phe (2)-Arg(3)-Asn(4) of the peptide is crucial for biological activity. Here we report on a focused structure-activity study of Phe(2) which has been replaced with a series of coded and noncoded amino acids. Thirty-one human NPS analogues were synthesized and pharmacologically tested for intracellular calcium mobilization by using HEK293 cells stably expressing the mouse NPSR. The results of this study demonstrated the following NPS position 2 structure-activity features: (i) lipophilicity but not aromaticity is crucial, (ii) both the size of the chemical moiety and its distance from the peptide backbone are important for biological activity, and (iii) this position plays a role in both receptor binding and activation, since [4,4'-biphenyl-Ala(2)]hNPS behaved as a partial agonist.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18181564     DOI: 10.1021/jm701204n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide s receptor.

Authors:  Samarjit Patnaik; Juan J Marugan; Ke Liu; Wei Zheng; Noel Southall; Seameen J Dehdashti; Annika Thorsell; Markus Heilig; Lauren Bell; Michelle Zook; Bob Eskay; Kyle R Brimacombe; Christopher P Austin
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

2.  Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings.

Authors:  L Raiteri; E Luccini; C Romei; S Salvadori; G Calò
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

3.  Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.

Authors:  Remo Guerrini; Valeria Camarda; Claudio Trapella; Girolamo Caló; Anna Rizzi; Chiara Ruzza; Stella Fiorini; Erika Marzola; Rainer K Reinscheid; Domenico Regoli; Severo Salvadori
Journal:  J Med Chem       Date:  2009-07-09       Impact factor: 7.446

4.  In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.

Authors:  Valeria Camarda; Anna Rizzi; Chiara Ruzza; Silvia Zucchini; Giuliano Marzola; Erika Marzola; Remo Guerrini; Severo Salvadori; Rainer K Reinscheid; Domenico Regoli; Girolamo Calò
Journal:  J Pharmacol Exp Ther       Date:  2008-10-29       Impact factor: 4.030

5.  Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.

Authors:  Remo Guerrini; Valeria Camarda; Claudio Trapella; Girolamo Calò; Anna Rizzi; Chiara Ruzza; Stella Fiorini; Erika Marzola; Rainer K Reinscheid; Domenico Regoli; Severo Salvadori
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

Review 6.  Pharmacology, Physiology and Genetics of the Neuropeptide S System.

Authors:  Rainer K Reinscheid; Chiara Ruzza
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-23

7.  Neuropeptide S-mediated facilitation of synaptic transmission enforces subthreshold theta oscillations within the lateral amygdala.

Authors:  Susanne Meis; Oliver Stork; Thomas Munsch
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

8.  Multiple polymorphisms affect expression and function of the neuropeptide S receptor (NPSR1).

Authors:  Francesca Anedda; Marco Zucchelli; Danika Schepis; Anna Hellquist; Lucia Corrado; Sandra D'Alfonso; Adnane Achour; Gerald McInerney; Alejandro Bertorello; Mikael Lördal; Ragnar Befrits; Jan Björk; Francesca Bresso; Leif Törkvist; Jonas Halfvarson; Juha Kere; Mauro D'Amato
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

9.  In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative.

Authors:  Chiara Ruzza; Anna Rizzi; Davide Malfacini; Alice Pulga; Salvatore Pacifico; Severo Salvadori; Claudio Trapella; Rainer K Reinscheid; Girolamo Calo; Remo Guerrini
Journal:  Pharmacol Res Perspect       Date:  2015-01-05

10.  Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies.

Authors:  Chiara Ruzza; Federica Ferrari; Remo Guerrini; Erika Marzola; Delia Preti; Rainer K Reinscheid; Girolamo Calo
Journal:  Pharmacol Res Perspect       Date:  2018-12-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.